申请人:HOFFMANN LA ROCHE
公开号:WO2009013211A2
公开(公告)日:2009-01-29
The invention is concerned with novel pyrazol derivatives of formula (I), wherein formula (II), R1, R2, R3, R4, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor and/or CCR-5 receptor and can be used as medicaments.